You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
23 March 2026 - Healthcare solutions provider GE HealthCare (Nasdaq: GEHC) announced on Monday that it has received 510(k) clearance from the U.S. Food and Drug Administration for Photonova Spectra, its next-generation photon-counting CT system. The ...
23 March 2026 - Biopharmaceutical company HUTCHMED (China) Limited (Nasdaq: HCM) (AIM: HCM) (HKEX: 13) announced on Monday that it has initiated a registrational Phase III clinical trial of HMPL-760 in combination with R-GemOx in patients with relaps...
23 March 2026 - US biopharmaceutical company Pfizer Inc (NYSE:PFE) and French vaccine company Valneva SE (Nasdaq:VALN) (Euronext Paris:VLA) on Monday reported positive topline results from the Phase 3 VALOR trial of their Lyme disease vaccine candida...
23 March 2026 - Pharmaceutical company GSK plc (LSE: GSK) (NYSE: GSK) declared on Monday that it has received Orphan Drug Designation in Japan for its investigational antibody-drug conjugate, risvutatug rezetecan, for the treatment of small-cell lung...
23 March 2026 - TheraCryf plc (AIM: TCF), a UK-based biotech company that develops new medicines for addiction and other neuropsychiatric disorders, announced on Monday that it has completed preclinical dose range finding studies for its lead orexin-...
23 March 2026 - PANTHERx Rare Pharmacy, a specialty pharmacy focused on rare and orphan diseases, announced on Friday that it has ben selected by biopharmaceutical company Rhythm Pharmaceuticals Inc (Nasdaq:RYTM) as the exclusive US pharmacy distribu...
23 March 2026 - Chinese biopharmaceutical company Dizal (SSE:688192) announced on Saturday that its multinational Phase 3 WU-KONG28 study evaluating ZEGFROVY (sunvozertinib) monotherapy as first-line treatment in non-small cell lung cancer (NSCLC) wi...